避妊薬市場：タイプ別、投与経路別、年齢層別、流通チャネル別、地域別

世界の避妊薬市場は、2025年に197億9,000万米ドルと推定され、2032年には471億4,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は13.2%で成長する見込みです。

図.避妊薬市場シェア（%）、2025年地域別

避妊用ピルの世界市場は、過去数十年にわたって着実な成長を遂げています。避妊用ピルは、一般に避妊薬として知られ、女性ホルモンであるエストロゲンとプロゲステロンの合成版を含んでいます。排卵を抑制し、子宮頸管粘液と子宮内膜を変化させることで妊娠を防ぐために経口投与されます。家族計画に対する考え方の変化、予定外の妊娠に対する懸念の高まり、性の健康に対する意識の高まり、避妊オプションに関する規制規範の厳格化などが、避妊薬の需要を世界的に押し上げています。さらに、女性の労働参加の増加と妊娠の遅れが経口避妊薬の受容をさらに増大させています。

市場力学：

女性の識字率の上昇とエンパワーメントが避妊薬市場を前進させる主な要因です。女性のリプロダクティブ・ヘルスと権利に関する意識の高まりは、妊娠を遅らせたり計画的に妊娠するための避妊薬を広く受け入れることにつながっています。急速な都市化、ライフスタイルの変化、近代的ヘルスケアへの容易なアクセスが、経口避妊薬を選ぶ女性を増やしています。同時に、避妊におけるアンメット・メディカル・ニーズを解決するための技術革新と同様に、有効性が向上し副作用の少ない新製品の出現は、市場プレーヤーに有利な成長機会を生み出しています。しかし、代替家族計画法や避妊器具の存在、血栓、うつ病、体重変化などホルモン剤に伴う副作用が市場成長の妨げとなっています。さらに、一部の地域では社会的烙印や宗教的遠慮が避妊薬の需要を抑制し続けています。

本調査の主な特徴

• 本レポートでは、世界の避妊薬市場を詳細に分析し、2024年を基準年とした予測期間（2025-2032年）の市場規模および複合年間成長率（CAGR）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益成長機会を明らかにし、この市場の魅力的な投資提案マトリックスについて解説しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要市場企業が採用する競合戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の避妊薬市場の主要企業プロファイルを掲載しています。
• このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
• 避妊薬の世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 世界の避妊薬市場を分析する際に使用される様々な戦略マトリックスを通じて、利害関係者は意思決定が容易になります。

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
• 避妊薬の人気の高まり
• 家族計画と避妊へのアクセスを促進するための政府の取り組みの拡大
  • 抑制要因
• 錠剤に伴う副作用
• 血栓や心血管疾患のリスク
  • 機会
• 新興諸国における需要の増加
• 避妊薬を選択する女性人口の増加
• 主なハイライト
• 最近の動向
• PEST分析
• PORTERの分析
• 最近の製品承認/発売
• 合併、買収、および提携

第4章 世界の避妊薬市場- コロナウイルス（COVID-19）パンデミックの影響

• COVID-19疫学
• 供給側と需要側の分析
• 経済への影響

第5章 世界の避妊薬市場、タイプ別、2020年～2032年

• 複合避妊薬
• 単相性錠剤
• 多相性錠剤
• 延長サイクルピル
• ホルモン避妊薬
• プロゲスチンのみのピル
• 緊急避妊薬
• レボノルゲストレルベース
• ウリプリスタル酢酸塩ベース

第6章 世界の避妊薬市場、投与経路別、2020年～2032年

• 経口
• 注射剤
• 子宮内
• 膣
• その他（パッチなど）

第7章 世界の避妊薬市場、年齢層別、2020年～2032年

• 青少年
• 大人

第8章 世界の避妊薬市場、流通チャネル別、2020年～2032年

• オンライン薬局
• 病院薬局
• 小売薬局

第9章 世界の避妊薬市場、地域別、2020年～2032年

• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東
• アフリカ

第10章 競合情勢

• 企業プロファイル
  • Bayer AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries
  • Merck &Co.
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players

第11章 セクション

• 参考文献
• 調査手法
• 出版社について

Global Contraceptives Market is estimated to be valued at USD 19.79 Bn in 2025 and is expected to reach USD 47.14 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.2% from 2025 to 2032.

Figure. Contraceptives Market Share (%), By Region 2025

Global contraceptive pill market has been witnessing steady growth over the past few decades. Contraceptive pills, commonly known as birth control pills, contain synthetic versions of the female sex hormones - estrogen and progesterone. They are taken orally to prevent pregnancy by inhibiting ovulation and altering cervical mucus and the lining of the uterus. Changing attitudes towards family planning, rising concern about unplanned pregnancies, growing sexual health awareness, and stricter regulatory norms regarding contraceptive options have boosted the demand for contraceptive pills globally. Moreover, increasing women workforce participation and delayed pregnancies have further augmented the acceptance of oral contraceptive drugs.

Market Dynamics:

Rising female literacy and empowerment are the primary drivers propelling the contraceptive pill market forward. Growing awareness about women's reproductive health and rights has led to a widespread acceptance of contraceptives to delay or plan pregnancies. Rapid urbanization, changing lifestyles, and easier access to modern healthcare are encouraging more women to opt for oral contraceptives. At the same time, the emergence of new products with improved efficacy and fewer side effects as well as innovations to address unmet medical needs in contraception are creating lucrative growth opportunities for market players. However, the presence of alternative family planning methods and contraceptive devices along with some side effects that are associated with hormonal pills such as blood clots, depression, and weight changes are hindering the market growth. Moreover, social stigma and religious reservations in some regions continue to restrain the demand for contraceptive pills.

Key Features of the Study:

• This report provides an in-depth analysis of the global contraceptive market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key market players
• It profiles key players in the global contraceptive market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries, Merck & Co., Janssen Pharmaceutical Companies, Allergan, Piramal Enterprises, Glenmark Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Mithra Pharmaceuticals, Gedeon Richter, HLL Lifecare, Cadila Healthcare, Organon and Other Prominent Players
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contraceptive market

Detailed Segmentation:

• Global Contraceptive Market, By Type
  • Combination Contraceptives
  • Monophasic pills
  • Multiphasic pills
  • Extended-cycle pills
  • Hormonal Contraceptives
  • Progestin-Only Pills
  • Emergency Contraceptives
  • Levonorgestrel-based
  • Ulipristal acetate-based
• Global Contraceptive Market, By Route of Administration
  • Oral
  • Injectable
  • Intrauterine
  • Vaginal
  • Others (Patches, etc.)
• Global Contraceptive Market, By Age Group
  • Adolescents
  • Adults
• Global Contraceptive Market, By Distribution Channel
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
• Global Contraceptive Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Bayer AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries
  • Merck & Co.
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Age Group
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers:
• Increasing popularity of contraceptive drugs
• Growing government initiatives for promoting access to family planning and contraceptives
  • Restraints
• Side effects associated with pills
• Risks of blood clots and cardiovascular diseases
  • Opportunities
• Growing demand in developing countries
• Growing female population opting for contraceptive drugs
• Key Highlights
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Recent Product Approvals/Launches
• Mergers, Acquisitions, and Collaborations

4. Global Contraceptive Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Contraceptive Market, By Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Combination Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Monophasic pills
• Multiphasic pills
• Extended-cycle pills
• Hormonal Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Progestin-Only Pills
• Emergency Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Levonorgestrel-based
• Ulipristal acetate-based

6. Global Contraceptive Market, By Route of Administration, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Intrauterine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Vaginal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Others (Patches, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Contraceptive Market, By Age Group, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adolescents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Contraceptive Market, By Distribution Channel, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Contraceptive Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021 - 2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profile
  • Bayer AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Pfizer Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Teva Pharmaceutical Industries
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Merck & Co.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players
• Analyst Views

11. Section

• References
• Research Methodology
• About us